Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 7/20 | 0.40 |
| ▸ | HTR2A | P28223 | 7/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14767588 | 1.00 | AOC3 (0.46) | AOC3LMNAHRH1HTR2ASIGMAR1 | |
| Acetic Acid SCHEMBL27813855 | 0.90 | MTNR1A (0.44) | AOC3LMNA | |
| SCHEMBL27999449 | 0.87 | CYP17A1 (0.46) | TAAR1 | |
| SCHEMBL6681384 | 0.86 | POLB (0.45) | AOC3LMNAHRH1HTR2ASIGMAR1 | |
| SCHEMBL6682968 | 0.85 | SIGMAR1 (0.44) | LMNAHRH1HTR2ASIGMAR1 | |
| SCHEMBL6680881 | 0.83 | HTR2A (0.45) | HTR2ASIGMAR1 | |
| SCHEMBL6685419 | 0.83 | HTR2A (0.45) | HTR2ASIGMAR1 | |
| SCHEMBL10400302 | 0.81 | HTR2A (0.44) | HTR2ASIGMAR1 | |
| SCHEMBL3898638 | 0.80 | LMNA (0.52) | AOC3LMNAHRH1HTR2ATAAR1 | |
| SCHEMBL17816146 | 0.80 | LMNA (0.52) | AOC3LMNAHRH1HTR2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108929210-A | A kind of synthetic method of the fluoro- 2,2- dichloro propionic aldehyde of pesticide intermediate 3,3,3- tri- | 江苏扬农化工集团有限公司 | 2018-12-04 | — | — | CN | claimed |
| EP-2707335-A1 | OYXGEN-CAPTURING AGENTS FOR AQUEOUS SYSTEMS | Arkema France (FR) | 2014-03-19 | — | — | EP | claimed |
| WO-2012153058-A1 | OYXGEN-CAPTURING AGENTS FOR AQUEOUS SYSTEMS | ARKEMA FRANCE (FR) | 2012-11-15 | — | — | WO | claimed |
| US-20260042715-A1 | FLUORINATION PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2026-02-12 | — | — | US | disclosed |
| EP-4565550-A1 | FLUORINATION PROCESS | Royal College of Surgeons in Ireland (IE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4381026-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | Idemitsu Kosan Co.,Ltd. (JP) | 2024-06-12 | — | — | EP | disclosed |
| EP-4326731-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024028729-A1 | FLUORINATION PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023117835-A1 | ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| EP-4185655-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023057327-A1 | METHOD FOR FORMING AN ORGANIC ELEMENT OF AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |
| WO-2006085930-A9 | METHOD OF PREPARING ALUMINUM NANORODS | NANOMAT INC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2005087751-A2 | SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | WO | disclosed |
| EP-0985649-B1 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES (JP) | 2004-11-24 | — | — | EP | disclosed |
| EP-1254101-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | Novo Nordisk A/S (DK) | 2002-11-06 | — | — | EP | disclosed |
| US-6462248-B1 | THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS | TORAY INDUSTRIES, INC. (JP) | 2002-10-08 | — | — | US | disclosed |
| WO-2001055085-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | NOVO NORDISK A/S (DK) | 2001-08-02 | — | — | WO | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0773939-A1 | DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996003396-A1 | DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042715-A1 | FLUORINATION PROCESS | XDH, VGF, GTF2F1 | AOC3 513/4885LMNA 1389/4885HRH1 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.